Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded accessFrancesca Fumagalli, Alessandro Aiuti, Valeria Calbi et al.|The Lancet|2022Cited by 286
Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of <scp> CD4 <sup>+</sup> </scp> T‐cells for the treatment of Hyper <scp>IgM1</scp>Daniele Canarutto, Luigi Naldini, Elisabetta Rovelli et al.|The EMBO Journal|2023Cited by 10